Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on May 11, 2026, by Cellectis S.A., a foreign private issuer based in Paris, France, incorporates by reference the company's interim report for the three-month period ended March 31, 2026 (Exhibit 99.1). The filing serves to update U.S. investors on the company's status and incorporates the report into various registration statements on Forms F-3 and S-8.
Key Financial Metrics
The provided filing text is a cover sheet and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this excerpt. The detailed financial metrics are contained within the referenced Exhibit 99.1, which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the full interim report in Exhibit 99.1 for comparative analysis.
Guidance, Outlook, and Risks
No management commentary, forward-looking guidance, specific risk factors, or unusual items are detailed in the cover sheet text. The document notes that the information in Exhibit 99.1 is incorporated by reference into active registration statements.
Key Facts for Investor Verification
- Verify the full content of Exhibit 99.1 (Interim Report for the three months ended March 31, 2026) to obtain actual financial performance data.
- Confirm the status of the registration statements (Forms F-3 and S-8) listed in the incorporation by reference section.
- Note that the filing date is May 11, 2026, and the reporting period covers the first quarter of 2026.
- Identify the authorized signatory as André Choulika, Chief Executive Officer.